BAM
KURA icon

Blueshift Asset Management’s Kura Oncology KURA Stock Holding History

Blueshift Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33,936
Closed -$353K – 578
2025
Q4 		$353K Buy
+33,936
New +$356K 0.1% 285
2025
Q1 		– Sell
-20,031
Closed -$174K – 484
2024
Q4 		$174K Buy
+20,031
New +$288K 0.06% 348

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blueshift Asset Management's KURA Position: Q1 2026 in Review

Blueshift Asset Management sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 33,936 shares — an estimated $353K sold.

Blueshift Asset Management first reported a position in KURA in Q4 2024 and held it in 2 quarters. The position peaked at $353K in Q4 2025. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Blueshift Asset Management reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Blueshift Asset Management sold 33,936 Kura Oncology shares in Q1 2026, an estimated $353K.
  • Blueshift Asset Management first reported a position in Kura Oncology in Q4 2024 and held it in 2 quarters.
  • Blueshift Asset Management's Kura Oncology position peaked at $353K in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Blueshift Asset Management's 13F filing for Q1 2026, filed 14 May 2026.